<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Latacz G</submitter><funding>Narodowe Centrum Nauki</funding><pagination>1882-1890</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6256855</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(11)</volume><pubmed_abstract>Close structural analogues of 5-carboxamidotryptamine (5-CT) based on the newly discovered indole-imidazole scaffold were synthesized and evaluated to search for a 5-HT7 receptor agonist of higher selectivity. In vitro drug-likeness studies and in vivo pharmacological evaluation of potent and selective low-basicity 5-HT7 receptor agonists, previously published 7 (3-(1-ethyl-1H-imidazol-5-yl)-1H-indole-5-carboxamide, AH-494) and 13 (3-(1-methyl-1H-imidazol-5-yl)-1H-indole-5-carboxamide), have supported their usefulness as pharmacological tools. Comprehensive in vitro comparison studies between 7, 13 and the commonly used 5-CT showed their very similar ADMET properties. Compound 7 at 1 mg kg-1 reversed MK-801-induced disruption in novel object recognition in mice and alleviated stress-induce</pubmed_abstract><journal>MedChemComm</journal><pubmed_title>Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1H-imidazol-5-yl)-1H-indole-5-carboxamides, low-basicity 5-HT7 receptor agonists.</pubmed_title><pmcid>PMC6256855</pmcid><funding_grant_id>OPUS 2017/25/B/NZ7/02929</funding_grant_id><pubmed_authors>Cieslik P</pubmed_authors><pubmed_authors>Wozniak M</pubmed_authors><pubmed_authors>Hogendorf A</pubmed_authors><pubmed_authors>Lubelska A</pubmed_authors><pubmed_authors>Wieronska JM</pubmed_authors><pubmed_authors>Handzlik J</pubmed_authors><pubmed_authors>Hogendorf AS</pubmed_authors><pubmed_authors>Kiec-Kononowicz K</pubmed_authors><pubmed_authors>Bojarski AJ</pubmed_authors><pubmed_authors>Latacz G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1H-imidazol-5-yl)-1H-indole-5-carboxamides, low-basicity 5-HT7 receptor agonists.</name><description>Close structural analogues of 5-carboxamidotryptamine (5-CT) based on the newly discovered indole-imidazole scaffold were synthesized and evaluated to search for a 5-HT7 receptor agonist of higher selectivity. In vitro drug-likeness studies and in vivo pharmacological evaluation of potent and selective low-basicity 5-HT7 receptor agonists, previously published 7 (3-(1-ethyl-1H-imidazol-5-yl)-1H-indole-5-carboxamide, AH-494) and 13 (3-(1-methyl-1H-imidazol-5-yl)-1H-indole-5-carboxamide), have supported their usefulness as pharmacological tools. Comprehensive in vitro comparison studies between 7, 13 and the commonly used 5-CT showed their very similar ADMET properties. Compound 7 at 1 mg kg-1 reversed MK-801-induced disruption in novel object recognition in mice and alleviated stress-induce</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2025-04-18T11:42:26.799Z</modification><creation>2019-10-11T07:18:30Z</creation></dates><accession>S-EPMC6256855</accession><cross_references><pubmed>30568756</pubmed><doi>10.1039/c8md00313k</doi></cross_references></HashMap>